Biodesix Makes the Case for VeriStrat Through New Study Biodesix通过新的研究证明了VeriStrat的可行性 The Biodesix VeriStrat test received an extra dose of validation last week through a 1,048-patient study published in the Oncol

Bionano Genomics (hereafter referred to asBionano) was founded in 2004 as a biotechnology company in San Diego, USA. Itsoptical mapping system is the only physical mapping technology that can jointlyassemble and analyze the optical signals

MA activity in the liquid biopsy space is picking up as Bio-Techne said it will acquire Exosome Diagnostics for $250 million plus $325 million in potential milestones. Waltham, MA-based Exosome has developed the urine-based test ExoDx Prost

ChapterIGeneralProvisions Article1 TheseRegulationsareherebyformulatedwithaviewtostrengtheningthesupervisionandadministration ofmedicaldevices,ensuringtheirsafetyandeffectivenessandprotectinghumanhealthandlifesafety. Article2 Allunitsorindi

Notice of the application for booths in CACLP Expo 2016 Organized byBroad (Shanghai) Exhibition Business Co., Ltd. and supported by ChinaAssociation of In-vitro Diagnostics, CACLP Expo 2016 is going to be hosted onMarch 7th，2016 at Qujian